Biomarkers predicting outcome in patients with advanced renal cell carcinoma ... - UroToday PDF Print
UroToday903 patients with advanced renal cell carcinoma (RCC) were randomized to sorafenib 400 mg bid or placebo. ELISAs were performed on samples collected at

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.